| Financial Year |
March 31 2023 |
| Monetary Funds |
1,170,025,746.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,093,938.76 |
| Accounts Receivable |
251,014,552.99 |
| Advances to Suppliers |
6,355,940.80 |
| Other Receivables |
14,953,957.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
261,340,008.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
100,351,261.71 |
| Total Current Assets |
1,862,471,017.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
519,368,815.30 |
| Fixed Assetes |
433,934,826.82 |
| Under-construction Projects |
149,097,259.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,426,878.49 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,156,051.67 |
| Deferred Income Tax Assets |
33,328,333.59 |
| Other Non-Current Assets |
5,799,799.97 |
| Sub-Total of Non-Current Assets |
1,292,663,556.49 |
| Total Assets |
3,155,134,574.25 |
| Short-Term Loans |
542,933,600.00 |
| Trading Financial liabilities |
121,000.00 |
| Notes Payable |
89,007,185.99 |
| Accounts Payable |
201,223,019.12 |
| Accounts Received In Advance |
521,330.16 |
| Employee Compensation Payable |
28,982,230.07 |
| Taxes Payable |
19,226,889.70 |
| Interest Payable |
-- |
| Dividend Payable |
97,848.34 |
| Other payables |
79,240,169.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,107,669.55 |
| Other Current Liabilities |
6,890,334.49 |
| Sub-Total of Current Liabilities |
1,041,621,392.30 |
| Long-term Loans |
403,688,249.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,458,311.33 |
| Deferred Income Tax Liabilities |
235,627.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
459,414,792.33 |
| Total Liabilities |
1,501,036,184.63 |
| Paid-In Capital(Or Share Stock) |
297,108,930.00 |
| Capital Surplus |
494,319,477.99 |
| Surplus Reserve |
81,780,630.22 |
| LESS:Treasury Stock |
2,420,456.56 |
| Undistributed Profits |
780,376,059.42 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,654,098,389.62 |
| Owner's Equity（Stockholder's Equity） |
1,654,098,389.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,155,134,574.25 |
